MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS
The present invention relates to a therapeutic compound comprising : - an agent that inhibits the activity of at least one gene selected from the group consisting of FOXS1, CREB5, HIC1, IRF7, POU2F2, STAT4, TCF4, and/or - an agent that enhances the activity of at least one gene selected from the gro...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DUGAST-DARZACQ, Claire DARZACQ, Xavier NOIZET, Maïté |
| description | The present invention relates to a therapeutic compound comprising :
- an agent that inhibits the activity of at least one gene selected from the group consisting of FOXS1, CREB5, HIC1, IRF7, POU2F2, STAT4, TCF4, and/or
- an agent that enhances the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2 for use in the prevention and/or treatment of fibrosis, hypertrophic scar or keloid. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3301112B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3301112B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3301112B13</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHPxIOof9gGKxr4gTTcmmGbDJgqeapF4Ei3U_2MFH-BphmHm4tqSR33yiiErPmBOYGhyixAZzxiyowAqNNtvZVS5nRqQAeNqpuTSGuwlImemaJ2GpBUnmOYjenJNWorZvX-MZfXjQoDBrO2mDK-ujEN_K8_y7jBW1U5Kua9l9cfyATTjMxk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS</title><source>esp@cenet</source><creator>DUGAST-DARZACQ, Claire ; DARZACQ, Xavier ; NOIZET, Maïté</creator><creatorcontrib>DUGAST-DARZACQ, Claire ; DARZACQ, Xavier ; NOIZET, Maïté</creatorcontrib><description>The present invention relates to a therapeutic compound comprising :
- an agent that inhibits the activity of at least one gene selected from the group consisting of FOXS1, CREB5, HIC1, IRF7, POU2F2, STAT4, TCF4, and/or
- an agent that enhances the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2 for use in the prevention and/or treatment of fibrosis, hypertrophic scar or keloid.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200101&DB=EPODOC&CC=EP&NR=3301112B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200101&DB=EPODOC&CC=EP&NR=3301112B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DUGAST-DARZACQ, Claire</creatorcontrib><creatorcontrib>DARZACQ, Xavier</creatorcontrib><creatorcontrib>NOIZET, Maïté</creatorcontrib><title>MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS</title><description>The present invention relates to a therapeutic compound comprising :
- an agent that inhibits the activity of at least one gene selected from the group consisting of FOXS1, CREB5, HIC1, IRF7, POU2F2, STAT4, TCF4, and/or
- an agent that enhances the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2 for use in the prevention and/or treatment of fibrosis, hypertrophic scar or keloid.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHPxIOof9gGKxr4gTTcmmGbDJgqeapF4Ei3U_2MFH-BphmHm4tqSR33yiiErPmBOYGhyixAZzxiyowAqNNtvZVS5nRqQAeNqpuTSGuwlImemaJ2GpBUnmOYjenJNWorZvX-MZfXjQoDBrO2mDK-ujEN_K8_y7jBW1U5Kua9l9cfyATTjMxk</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>DUGAST-DARZACQ, Claire</creator><creator>DARZACQ, Xavier</creator><creator>NOIZET, Maïté</creator><scope>EVB</scope></search><sort><creationdate>20200101</creationdate><title>MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS</title><author>DUGAST-DARZACQ, Claire ; DARZACQ, Xavier ; NOIZET, Maïté</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3301112B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>DUGAST-DARZACQ, Claire</creatorcontrib><creatorcontrib>DARZACQ, Xavier</creatorcontrib><creatorcontrib>NOIZET, Maïté</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DUGAST-DARZACQ, Claire</au><au>DARZACQ, Xavier</au><au>NOIZET, Maïté</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS</title><date>2020-01-01</date><risdate>2020</risdate><abstract>The present invention relates to a therapeutic compound comprising :
- an agent that inhibits the activity of at least one gene selected from the group consisting of FOXS1, CREB5, HIC1, IRF7, POU2F2, STAT4, TCF4, and/or
- an agent that enhances the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2 for use in the prevention and/or treatment of fibrosis, hypertrophic scar or keloid.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3301112B1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A35%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DUGAST-DARZACQ,%20Claire&rft.date=2020-01-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3301112B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |